- GPSM2:
- G protein signaling modulator 2
Lollipop plot
Phosphosites location and occurrence
Structure
Phosphosite detection coverage
The frequency of phosphosite detection in the number of cohorts and tumor and normal samples
BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Site
| Sequence | Cohorts | Total | T | N | T | N | T | N | T | N | T | N | T | N | T | N | T | N | T | N | T | N |
S408 | PKLGRRHSMENMELM | 9 | 1039 | 56 | - | 74 | 52 | 66 | 59 | 99 | - | 108 | 62 | 78 | 69 | 106 | 96 | - | - | 68 | 31 | 6 | 9 |
T418 | NMELMKLTPEKVQNW | 1 | 14 | 14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
S470 | VLQDASNSIDHRIPN | 1 | 9 | - | - | - | - | - | - | 9 | - | - | - | - | - | - | - | - | - | - | - | - | - |
S483 | PNSQRKISADTIGDE | 5 | 90 | - | - | - | - | 14 | 13 | 36 | - | 7 | 3 | - | - | - | - | - | - | 4 | 1 | 9 | 3 |
T486 | QRKISADTIGDEGFF | 2 | 17 | - | - | 4 | 4 | - | - | - | - | - | - | - | - | 5 | 4 | - | - | - | - | - | - |
T523 | CHTASTTTSSTPPKM | 1 | 6 | 6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
S525 | TASTTTSSTPPKMML | 2 | 16 | - | - | - | - | - | - | - | - | 5 | 3 | - | - | - | - | 6 | 2 | - | - | - | - |
T526 | ASTTTSSTPPKMMLK | 4 | 153 | - | - | - | - | - | - | 81 | - | 6 | 3 | - | - | - | - | 36 | 8 | - | - | 10 | 9 |
S536 | KMMLKTSSVPVVSPN | 6 | 427 | - | - | - | - | 70 | 56 | 35 | - | 73 | 43 | 30 | 27 | 45 | 39 | - | - | - | - | 7 | 2 |
S541 | TSSVPVVSPNTDEFL | 8 | 195 | 7 | - | - | - | 25 | 20 | 18 | - | 43 | 25 | 20 | 18 | 4 | 4 | 4 | - | - | - | 5 | 2 |
Tumor and normal comparison
Site
| Sequence | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC |
---|---|---|---|---|---|---|---|---|---|---|---|---|
S408 | PKLGRRHSMENMELM | 1.6e-8 | - | 1e-8 | 1.8e-6 | - | -0.082 | 0.32 | 0.54 | - | 5.6e-4 | - |
T418 | NMELMKLTPEKVQNW | - | - | - | - | - | - | - | - | - | - | - |
S470 | VLQDASNSIDHRIPN | - | - | - | - | - | - | - | - | - | - | - |
S483 | PNSQRKISADTIGDE | - | - | - | - | - | - | - | - | - | - | - |
T486 | QRKISADTIGDEGFF | - | - | - | - | - | - | - | - | - | - | - |
T523 | CHTASTTTSSTPPKM | - | - | - | - | - | - | - | - | - | - | - |
S525 | TASTTTSSTPPKMML | - | - | - | - | - | - | - | - | - | - | - |
T526 | ASTTTSSTPPKMMLK | - | - | - | - | - | - | - | - | - | - | - |
S536 | KMMLKTSSVPVVSPN | -0.44 | - | - | -0.79 | - | -0.53 | -0.69 | -0.8 | - | - | - |
S541 | TSSVPVVSPNTDEFL | -0.16 | - | - | -0.069 | - | -0.014 | 0.067 | - | - | - | - |
Phenotype and mutation association
Signed p-values | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Phenotype | Site | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC |
KINASE-PSP_AurB/AURKB | S565 | 3.7e-13 | - | - | - | 0.017 | 2.9e-9 | 0.051 | 3.7e-4 | - | - | 0.016 |
KINASE-PSP_Chk1/CHEK1 | S565 | 6.7e-9 | - | - | 0.021 | 0.34 | 0.35 | 6.3e-3 | 7.7e-4 | 0.033 | - | 3.6e-3 |
HALLMARK_E2F_TARGETS | T526 | 3.9e-8 | - | - | - | 4.4e-6 | - | - | - | 0.019 | - | 9.8e-3 |
HALLMARK_G2M_CHECKPOINT | T526 | 5e-8 | - | - | - | 6.9e-6 | - | - | - | 0.013 | - | 0.014 |
HALLMARK_G2M_CHECKPOINT | S408 | 9.3e-8 | 1.1e-4 | 0.011 | -0.78 | 3.9e-4 | -0.9 | 0.046 | 0.21 | - | 0.021 | - |
HALLMARK_E2F_TARGETS | S408 | 1.3e-7 | 4.2e-4 | 0.018 | -0.67 | 2.7e-4 | -0.73 | 0.036 | 0.098 | - | 0.016 | - |
PERT-PSP_EGF | S565 | 2.4e-7 | 0.075 | - | 0.18 | 2.9e-3 | 0.021 | 0.054 | 0.049 | 0.47 | - | 0.11 |
KINASE-PSP_PKACA/PRKACA | S565 | 4.9e-7 | 0.16 | - | -0.086 | 0.006 | 6.1e-5 | 0.086 | 1.9e-5 | -0.69 | - | 0.03 |
chromosomal instability | S408 | 9e-7 | 3.4e-4 | 1.9e-3 | 0.019 | 2.1e-3 | -0.18 | 0.18 | 0.27 | - | 0.49 | - |
KINASE-PSP_CDK2 | S408 | 1.8e-6 | 3.6e-4 | 0.049 | -0.7 | 8.3e-4 | 0.97 | 0.027 | 0.4 | - | 0.055 | - |
Cis-association
Kinase association
Signed p-values | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kinase | Site | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC |
TRIM33 | S408 | 2.9e-14 | 0.019 | 0.084 | -0.77 | 2.2e-16 | -0.59 | 1.2e-4 | 7.5e-6 | - | 0.083 | - |
CDK1 | S408 | 1e-10 | 1.1e-4 | 2.1e-5 | -0.85 | 1.5e-4 | -0.57 | 0.011 | 0.07 | - | 5.5e-3 | - |
AURKB | T526 | 3e-9 | - | - | - | 4.7e-5 | - | - | - | 4.8e-4 | - | 6.8e-3 |
CDK1 | T526 | 1.7e-7 | - | - | - | 1.3e-4 | - | - | - | 9.4e-4 | - | 0.054 |
CDK13 | T526 | 3.3e-7 | - | - | - | 3.8e-5 | - | - | - | 7.2e-4 | - | 0.18 |
PBK | T526 | 5.2e-7 | - | - | - | 9.8e-5 | - | - | - | 0.015 | - | 0.018 |
RPS6KA3 | S565 | 5.4e-7 | 0.022 | - | 4.4e-3 | 0.18 | -0.46 | 0.16 | 3.2e-3 | 0.01 | - | 0.13 |
PRKDC | S408 | 1.7e-6 | 0.52 | 6.9e-4 | 0.12 | 1.4e-6 | -0.034 | 0.12 | 0.65 | - | 1.2e-3 | - |
MAP3K6 | S565 | 3.8e-6 | 0.059 | - | 0.6 | 0.32 | 0.093 | 0.027 | 0.067 | 0.037 | - | 0.063 |
SMG1 | S408 | 4.6e-6 | -0.75 | 0.073 | -0.11 | 1.3e-4 | 1.7e-3 | 1.4e-6 | 0.17 | - | -0.91 | - |
Phosphatase association
Signed p-values | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatase | Site | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC |
FBP1 | S408 | -7.1e-7 | -5.7e-3 | -2.2e-3 | 0.59 | -7.7e-5 | -0.014 | -0.042 | 0.61 | - | -0.42 | - |
DUSP3 | S408 | -5.1e-6 | -0.079 | -0.024 | -0.99 | -4.6e-4 | 0.24 | -3.7e-3 | -0.11 | - | -0.043 | - |
PHPT1 | S408 | -1.1e-5 | -4.7e-3 | -0.029 | 0.044 | -0.72 | -0.28 | -0.036 | -5.4e-3 | - | -1.8e-3 | - |
TNS2 | S408 | -1.3e-5 | -0.003 | -0.017 | 0.87 | -0.03 | -0.062 | -0.36 | -0.23 | - | -0.33 | - |
TNS3 | S408 | -7.4e-5 | 0.58 | -0.67 | 0.58 | -1.3e-5 | -1.3e-5 | -0.034 | 0.33 | - | -0.043 | - |
IMPA1 | T526 | -8.0e-5 | - | - | - | -5.2e-3 | - | - | - | -0.083 | - | -0.021 |
PHPT1 | S565 | -1.5e-4 | -0.081 | - | -0.89 | 0.71 | -0.77 | -0.26 | -0.19 | -9.3e-4 | - | -1.6e-3 |
PNKP | S565 | -1.7e-4 | -0.56 | - | 0.17 | -2.6e-4 | -5.7e-4 | -0.26 | -0.1 | -0.024 | - | 0.49 |
G6PC | S408 | -2.0e-4 | - | -2.0e-4 | - | - | - | - | - | - | - | - |
CTDNEP1 | S541 | -2.2e-4 | - | - | - | -0.081 | -6.3e-3 | -0.056 | - | - | - | - |